Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters

Database
Country/Region as subject
Language
Publication year range
1.
Acta Trop ; 257: 107299, 2024 Sep.
Article in English | MEDLINE | ID: mdl-38955320

ABSTRACT

Q fever is a re-emerging zoonosis whose epidemiological cycle in ruminants is well defined, while the role of other species (including pets) is still debated. In this study, the serological and molecular prevalence of Coxiella burnetii in a sample of dogs in the Campania region, southern Italy was evaluated. A seroprevalence of 5.97 % (16/268) was observed using a commercial multispecies ELISA, compared to only 2.7 % (5/197) at the molecular level. No risk factors correlated with higher levels of exposure except for the size of the animal (small dogs showed significantly higher seroprevalence). Positive samples were further evaluated for reactivity to phase I and II antigens using IFA and phase-specific ELISAs (for specific IgG detection). Two animals showed antibodies against both phases of infection, suggesting that Coxiella burnetii seroconversion in dogs follows similar dynamics to those observed in ruminants. One of the five samples that showed positive results in real-time PCR was confirmed at the PCR endpoint and showed similarity with other Coxiella spp. strains detected in tick and dog samples when sequenced. In this study, we demonstrated exposure to Coxiella burnetii for different categories of dogs in southern Italy, including pet dogs living indoors. Since reports of transmission of infection from pets to humans have been described in both rural and urban areas, careful surveillance of these species is also necessary. In the lack of additional information, comprehending the risk to humans requires monitoring of wild and domestic animal populations.


Subject(s)
Antibodies, Bacterial , Coxiella burnetii , Dog Diseases , Enzyme-Linked Immunosorbent Assay , Q Fever , Animals , Dogs , Q Fever/epidemiology , Q Fever/veterinary , Italy/epidemiology , Coxiella burnetii/immunology , Coxiella burnetii/genetics , Coxiella burnetii/isolation & purification , Dog Diseases/epidemiology , Dog Diseases/microbiology , Seroepidemiologic Studies , Antibodies, Bacterial/blood , Male , Female , Immunoglobulin G/blood , Real-Time Polymerase Chain Reaction
2.
Acta Virol ; 57(2): 229-37, 2013.
Article in English | MEDLINE | ID: mdl-23600879

ABSTRACT

Coxiella burnetii is an intracellular, Gram-negative bacterium and causative agent of Q fever. In humans, the disease ranges mostly from a flu-like illness and self-recovering mild pneumonia to severe meningoencephalitis, myocarditis or endocarditis. Recent molecular and biochemical/immunological advances, along with improved instrumentation, have provided unique insight into the host-parasite interrelationship and revealed previously unknown virulence strategies of C. burnetii. Noticeable progress has also been achieved in gaining a better understanding of the role of two major outer membrane components - lipopolysaccharide (LPS) and proteins in the life and immunopathobiology of the bacterium. Detailed glycomic studies have brought indispensable structural and functional information on LPS and its role in pathogenesis and immunity of Q fever. Recent proteomic studies have brought a deeper insight into the pathogen`s physiology, virulence and development and offered new possibilities in the investigation of inter/intra-species variation. This review will focus on advances in glycomics and proteomics of C. burnetii providing information on unique glycan and protein species, which together with other findings in the field, might lead to both a better understanding of this unusual pathogen and improvements in Q fever diagnosis and therapy.


Subject(s)
Coxiella burnetii/genetics , Coxiella burnetii/metabolism , Q Fever/microbiology , Amino Acid Sequence , Carbohydrate Sequence , Glycomics/methods , Humans , Molecular Sequence Data , Proteomics/methods
SELECTION OF CITATIONS
SEARCH DETAIL